2020
Virtual group consultations offer continuity of care globally during Covid‐19
Birrell F, Lawson R, Sumego M, Lewis J, Harden A, Taveira T, Stevens J, Manson A, Pepper L, Ickovics J. Virtual group consultations offer continuity of care globally during Covid‐19. Lifestyle Medicine 2020, 1: e17. PMID: 38607797, PMCID: PMC7883187, DOI: 10.1002/lim2.17.Peer-Reviewed Original ResearchContinuity of careVirtual careCOVID-19Group consultationBetter health outcomesClinical trialsObservational studyCare settingsLifestyle medicineAbstract COVID-19Health outcomesHealthcare providersCare supportPandemic onsetCareConsultationPeer supportFront-line experienceWidespread implementationUnpublished dataRepresentative dataPatientsVirtual groupsNew team membersTrials
2013
Group Prenatal Care: Model Fidelity and Outcomes
Novick G, Reid A, Lewis J, Kershaw T, Rising S, Ickovics J. Group Prenatal Care: Model Fidelity and Outcomes. Journal Of Midwifery & Women's Health 2013, 58: 586-586. DOI: 10.1111/jmwh.12123.Peer-Reviewed Original ResearchPreterm birthGroup prenatal carePrenatal carePerinatal outcomesCenteringPregnancy modelLower oddsAdequate careAdequacy of careCenteringPregnancy groupClinical predictorsUrban clinicCare sessionsMedical recordsMonths postpartumClinical trialsAssociation of processClinical practiceInadequate careIndividual careSecondary analysisCenteringPregnancyCareLower likelihoodContent fidelityBirth
2002
Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
Ickovics J, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR, Acosta E, Barnett R, Bell D, Cannmann S, Eron J, Fischl M, Marschner I, Martinez A, Morse G, Pettinelli C, Sommadossi J, Wood K, Murphy R, Priller N, Sha B, French N, van der Horst C, Marcus C, Lane T, Horton J, Schooley R, Putnam B, Shugarts D, Johnson S, Fife K, Black J, Heise D, Todd K, Bagur J, Vazquez G, Lopez I, Ramirez V, Hill R, Wright S, McCulloch B, Saag M, Slamowitz D, Cain P, Merigan T, Tallman V, Greisberger C, Shoemaker M, Lewis M, Hewitt R, Havlir D, Nuffer K, Wininger D, Watson S, Clark J, Jackson C, Rodriguez A, Scerpella E, Tebas P, Stiffler T, Royal M, Powderly W, Collier A, Storey S, Houseworth L, Conley N, Lederman M, Kalayjian B, Ingersol K, McVey R, Gluckman S, Helker C, Kappes R, Kim D, Albrecht M, Koziol C, Govan; T, Miles S, Chafey S, Mitsuyasu R, Sacks H, Mildvan D, Shikuma C, Millard M, Souza S. Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370. Antiviral Therapy 2002, 7: 185-193. PMID: 12487386, DOI: 10.1177/135965350200700308.Peer-Reviewed Original ResearchConceptsPlasma HIV-1 RNA levelsHIV-1 RNA levelsCD4 cell countWeek 24Adherence ratesClinical trialsBaseline plasma HIV-1 RNA levelsAdult AIDS Clinical Trials GroupCell countAIDS Clinical Trials GroupRNA levelsAIDS clinical trialsAdverse clinical eventsAssociation of adherenceOverall adherence rateDeterminants of adherenceClinical Trials GroupSelf-reported adherencePredictors of adherencePatterns of adherenceNon-nucleoside reversePotential confounding variablesVirological outcomesAntiretroviral therapyAdverse events
2000
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, Wu A, GROUP P. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000, 12: 255-266. PMID: 10928201, DOI: 10.1080/09540120050042891.Peer-Reviewed Original ResearchConceptsAdult AIDS Clinical Trials GroupCent of patientsClinical trialsAntiretroviral therapyAdherence instrumentAIDS Clinical Trials GroupCombination antiretroviral therapyClinical Trials GroupSelf-reported adherenceHIV clinical trialsAdherent patientsAntiretroviral medicationsTrial groupLow adherenceSelf-report questionnairesCommon reasonPatientsDrug resistanceTrialsImproved healthMedicationsProtease inhibitorsQuestionnaireDoseAdherence
1999
Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research
Ethier K, Rodriguez M, Fox-Tierney R, Martin C, Friedland G, Ickovics J. Recruitment in AIDS Clinical Trials: Investigation of Sociodemographic and Psychosocial Factors Affecting Participation in Clinical Research. AIDS And Behavior 1999, 3: 219-230. DOI: 10.1023/a:1025456527845.Peer-Reviewed Original ResearchTrial participantsIDU historyClinical trialsAIDS clinical trialsGroup of HIVTrial regimenMedical therapyPsychosocial factorsHIV therapeuticsClinical researchTrial resultsTrialsBehavioral factorsHIVSociodemographic dimensionsPrimary objectiveParticipantsNonparticipantsRegimenPatientsTherapyMSMSociodemographicsRecruitmentAdherence: a necessity for successful HIV combination therapy.
Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999, 13 Suppl A: s271-8. PMID: 10885784.Peer-Reviewed Original ResearchConceptsCombination therapyHIV/AIDSHIV combination therapySuccessful treatment outcomeEmergence of resistancePatient adherenceClinical trialsDisease progressionLong-term benefitsRisk factorsHIV therapyTreatment outcomesTherapyAdherence researchResistant strainsHealth benefitsAdherenceIntervention programsVirus breakthroughAIDSIntervention effortsDifferent populationsValid methodFocused effortsHIV
1997
Adherence in AIDS clinical trials: A framework for clinical research and clinical care
Ickovics J, Meisler A. Adherence in AIDS clinical trials: A framework for clinical research and clinical care. Journal Of Clinical Epidemiology 1997, 50: 385-391. PMID: 9179096, DOI: 10.1016/s0895-4356(97)00041-3.Peer-Reviewed Original ResearchConceptsClinical trialsAIDS clinical trialsPoor medication adherenceAssessment of adherencePatient-provider relationshipClinical trial dataProtease inhibitor drugsTreatment regimenMedication adherenceMedical adherencePatient participationClinical careDrug failureTherapeutic outcomesViral resistanceNew treatmentsPatient careTrial dataTherapeutic valueClinical settingClinical interventionsClinical researchInhibitor drugsTrialsGood adherence